Oscar Health (OSCR) Stock Forecast, Price Target & Predictions
OSCR Stock Forecast
Oscar Health stock forecast is as follows: an average price target of $20.20 (represents a 26.41% upside from OSCR’s last price of $15.98) and a rating consensus of 'Buy', based on 6 wall street analysts offering a 1-year stock forecast.
OSCR Price Target
The average price target for Oscar Health (OSCR) is $20.20 based on 1-year price targets from 6 Wall Street analysts in the past 3 months, with a price target range of $28.00 to $5.00. This represents a potential 26.41% upside from OSCR's last price of $15.98.
OSCR Analyst Ratings
According to 6 Wall Street analysts, Oscar Health's rating consensus is 'Buy'. The analyst rating breakdown for OSCR stock is 0 'Strong Buy' (0.00%), 3 'Buy' (50.00%), 3 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Oscar Health Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 08, 2024 | Jessica Tassan | Piper Sandler | $28.00 | $18.38 | 52.34% | 75.22% |
| Jun 25, 2024 | Jessica Tassan | Piper Sandler | $25.00 | $17.64 | 41.72% | 56.45% |
| Jun 12, 2024 | Stephen Baxter | Wells Fargo | $27.00 | $20.01 | 34.93% | 68.96% |
| Jun 10, 2024 | Nathan Rich | Goldman Sachs | $21.00 | $20.21 | 3.91% | 31.41% |
| Mar 21, 2024 | John Ransom | Raymond James | $20.00 | $13.76 | 45.35% | 25.16% |
| Nov 15, 2022 | Stephen Baxter | Wells Fargo | $4.00 | $2.89 | 38.41% | -74.97% |
| Nov 14, 2022 | - | Morgan Stanley | $5.00 | $2.95 | 69.49% | -68.71% |
| Sep 01, 2022 | - | Morgan Stanley | $9.00 | $6.04 | 48.88% | -43.68% |
| Jun 09, 2022 | - | Morgan Stanley | $12.00 | $5.22 | 129.89% | -24.91% |
The latest Oscar Health stock forecast, released on Aug 08, 2024 by Jessica Tassan from Piper Sandler, set a price target of $28.00, which represents a 52.34% increase from the stock price at the time of the forecast ($18.38), and a 75.22% increase from OSCR last price ($15.98).
Oscar Health Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | 5 |
| Avg Price Target | - | - | $24.20 |
| Last Closing Price | $15.98 | $15.98 | $15.98 |
| Upside/Downside | -100.00% | -100.00% | 51.44% |
In the current month, the average price target of Oscar Health stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Oscar Health's last price of $15.98. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 07, 2024 | Sandler O'Neill | Underperform | Underperform | Hold |
| Oct 07, 2024 | UBS | Neutral | Neutral | Hold |
| Oct 07, 2024 | UBS | - | Neutral | Initialise |
| Sep 10, 2024 | Sandler O'Neil | Underperform | Underperform | Hold |
| Sep 10, 2024 | Sandler O'Neill | Overweight | Overweight | Hold |
| Aug 08, 2024 | Wells Fargo | Buy | Buy | Hold |
| Aug 08, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| Jun 25, 2024 | Piper Sandler | - | Overweight | Initialise |
| Jun 12, 2024 | Wells Fargo | Overweight | Overweight | Hold |
| Jun 10, 2024 | Goldman Sachs | Neutral | Neutral | Hold |
Oscar Health's last stock rating was published by Sandler O'Neill on Oct 07, 2024. The company gave OSCR a "Underperform" rating, the same as its previous rate.
Oscar Health Financial Forecast
Oscar Health Revenue Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.43B | $1.44B | $1.52B | $1.47B | $1.04B | $40.09M | $1.02B | $1.01B | $520.33M | $462.19M | $549.75M | $388.69M |
| Avg Forecast | $3.33B | $3.26B | $3.22B | $3.17B | $2.86B | $2.86B | $2.88B | $2.82B | $2.89B | $2.85B | $2.83B | $2.74B | $2.46B | $2.33B | $2.13B | $1.99B | $1.43B | $1.42B | $1.38B | $1.27B | $1.18B | $1.07B | $1.10B | $1.03B | $564.51M | $543.73M | $588.30M | $597.79M |
| High Forecast | $3.42B | $3.35B | $3.30B | $3.25B | $2.94B | $2.94B | $2.95B | $2.90B | $2.97B | $2.93B | $2.91B | $2.87B | $2.53B | $2.36B | $2.19B | $2.04B | $1.46B | $1.43B | $1.42B | $1.31B | $1.21B | $1.07B | $1.10B | $1.03B | $564.51M | $543.73M | $588.30M | $597.79M |
| Low Forecast | $3.25B | $3.18B | $3.14B | $3.09B | $2.79B | $2.79B | $2.81B | $2.75B | $2.82B | $2.78B | $2.77B | $2.63B | $2.45B | $2.29B | $2.08B | $1.94B | $1.39B | $1.42B | $1.35B | $1.24B | $1.15B | $1.07B | $1.10B | $1.03B | $564.51M | $543.73M | $588.30M | $597.79M |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 1.01% | 1.10% | 1.15% | 0.88% | 0.04% | 0.93% | 0.98% | 0.92% | 0.85% | 0.93% | 0.65% |
Oscar Health's average Quarter revenue forecast for Mar 24 based on 1 analysts is $1.99B, with a low forecast of $1.94B, and a high forecast of $2.04B. OSCR's average Quarter revenue forecast represents a 39.05% increase compared to the company's last Quarter revenue of $1.43B (Dec 23).
Oscar Health EBITDA Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-145.48M | $-58.24M | $-6.53M | $-25.36M | $-216.89M | $-181.11M | $-102.04M | $-65.61M | $-194.67M | $-209.30M | $-68.66M | $-79.31M |
| Avg Forecast | $-1.05B | $-1.03B | $-1.02B | $-1.00B | $-904.00M | $-905.39M | $-909.30M | $-892.67M | $-913.91M | $-902.43M | $-896.21M | $-867.47M | $-778.26M | $-736.49M | $-674.36M | $-46.51M | $-451.07M | $-449.61M | $-437.79M | $-42.29M | $-265.38M | $-341.77M | $-350.58M | $-38.44M | $-180.60M | $-173.95M | $-188.21M | $-64.26M |
| High Forecast | $-1.03B | $-1.01B | $-992.46M | $-977.25M | $-882.03M | $-883.38M | $-887.20M | $-870.97M | $-891.70M | $-880.49M | $-874.42M | $-830.16M | $-775.11M | $-725.44M | $-657.97M | $-37.21M | $-440.11M | $-447.81M | $-427.15M | $-33.83M | $-212.30M | $-341.77M | $-350.58M | $-30.75M | $-180.60M | $-173.95M | $-188.21M | $-51.41M |
| Low Forecast | $-1.08B | $-1.06B | $-1.04B | $-1.03B | $-928.11M | $-929.54M | $-933.55M | $-916.48M | $-938.29M | $-926.50M | $-920.11M | $-907.89M | $-799.02M | $-747.55M | $-692.35M | $-55.82M | $-463.10M | $-451.87M | $-449.46M | $-50.74M | $-318.45M | $-341.77M | $-350.58M | $-46.13M | $-180.60M | $-173.95M | $-188.21M | $-77.12M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.32% | 0.13% | 0.01% | 0.60% | 0.82% | 0.53% | 0.29% | 1.71% | 1.08% | 1.20% | 0.36% | 1.23% |
undefined analysts predict OSCR's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Oscar Health's previous annual EBITDA (undefined) of $NaN.
Oscar Health Net Income Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-150.03M | $-65.40M | $-15.53M | $-39.63M | $-226.56M | $-193.55M | $-112.13M | $-77.32M | $-197.74M | $-212.75M | $-73.07M | $-87.37M |
| Avg Forecast | $-34.03M | $106.97M | $187.19M | $286.87M | $-87.37M | $16.95M | $75.65M | $166.00M | $-107.09M | $-2.09M | $77.61M | $163.47M | $-144.70M | $-41.67M | $39.30M | $-53.27M | $-175.64M | $-114.87M | $-53.85M | $-48.43M | $-271.18M | $-218.56M | $-145.50M | $-44.03M | $-297.42M | $-220.80M | $-142.26M | $-70.80M |
| High Forecast | $-32.96M | $110.68M | $193.68M | $296.81M | $-84.61M | $17.53M | $78.28M | $171.76M | $-103.70M | $-2.02M | $80.30M | $210.93M | $-120.17M | $-40.35M | $39.34M | $-42.62M | $-170.09M | $-96.85M | $-52.15M | $-38.75M | $-216.94M | $-218.56M | $-145.50M | $-35.22M | $-297.42M | $-220.80M | $-142.26M | $-56.64M |
| Low Forecast | $-35.21M | $103.59M | $181.28M | $277.80M | $-90.40M | $16.41M | $73.26M | $160.76M | $-110.80M | $-2.16M | $75.16M | $116.01M | $-166.77M | $-43.11M | $39.26M | $-63.93M | $-181.73M | $-128.38M | $-55.72M | $-58.12M | $-325.42M | $-218.56M | $-145.50M | $-52.83M | $-297.42M | $-220.80M | $-142.26M | $-84.96M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.85% | 0.57% | 0.29% | 0.82% | 0.84% | 0.89% | 0.77% | 1.76% | 0.66% | 0.96% | 0.51% | 1.23% |
Oscar Health's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. OSCR's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Oscar Health SG&A Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $85.61M | $75.50M | $76.45M | $102.15M | $75.81M | $78.56M | $80.75M | $74.66M | $89.34M | $61.27M | $50.91M | $63.06M |
| Avg Forecast | $501.44M | $491.69M | $484.87M | $477.44M | $430.91M | $431.58M | $433.44M | $425.51M | $435.64M | $430.16M | $427.20M | $413.50M | $370.98M | $351.07M | $321.45M | $52.93M | $215.01M | $214.32M | $208.68M | $48.12M | $121.79M | $160.99M | $165.15M | $43.74M | $85.07M | $81.94M | $88.66M | $51.10M |
| High Forecast | $514.82M | $504.81M | $497.80M | $490.17M | $442.41M | $443.09M | $445.00M | $436.86M | $447.26M | $441.64M | $438.59M | $432.77M | $380.87M | $356.34M | $330.02M | $63.51M | $220.75M | $215.39M | $214.25M | $57.74M | $146.15M | $160.99M | $165.15M | $52.49M | $85.07M | $81.94M | $88.66M | $61.32M |
| Low Forecast | $489.25M | $479.74M | $473.08M | $465.83M | $420.44M | $421.08M | $422.90M | $415.17M | $425.05M | $419.70M | $416.81M | $395.71M | $369.47M | $345.80M | $313.64M | $42.34M | $209.79M | $213.46M | $203.61M | $38.49M | $97.43M | $160.99M | $165.15M | $34.99M | $85.07M | $81.94M | $88.66M | $40.88M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.40% | 0.35% | 0.37% | 2.12% | 0.62% | 0.49% | 0.49% | 1.71% | 1.05% | 0.75% | 0.57% | 1.23% |
Oscar Health's average Quarter SG&A projection for Mar 24 is $52.93M, based on 1 Wall Street analysts, with a range of $42.34M to $63.51M. The forecast indicates a -38.17% fall compared to OSCR last annual SG&A of $85.61M (Dec 23).
Oscar Health EPS Forecast
| Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 1 | 1 | 1 | 1 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.66 | $-0.29 | $-0.07 | $-0.18 | $-1.05 | $-0.91 | $-0.53 | $-0.37 | $-0.94 | $-1.02 | $-0.35 | $-0.98 |
| Avg Forecast | $-0.14 | $0.44 | $0.77 | $1.18 | $-0.36 | $0.07 | $0.31 | $0.68 | $-0.44 | $-0.01 | $0.32 | $0.67 | $-0.60 | $-0.17 | $0.16 | $0.27 | $-0.72 | $-0.47 | $-0.22 | $-0.06 | $-1.14 | $-0.72 | $-0.48 | $-0.21 | $-0.98 | $-0.73 | $-0.47 | $-0.53 |
| High Forecast | $-0.14 | $0.46 | $0.80 | $1.22 | $-0.35 | $0.07 | $0.32 | $0.71 | $-0.43 | $-0.01 | $0.33 | $0.87 | $-0.49 | $-0.17 | $0.16 | $0.28 | $-0.70 | $-0.40 | $-0.21 | $-0.06 | $-1.10 | $-0.72 | $-0.48 | $-0.21 | $-0.98 | $-0.73 | $-0.47 | $-0.53 |
| Low Forecast | $-0.14 | $0.43 | $0.75 | $1.14 | $-0.37 | $0.07 | $0.30 | $0.66 | $-0.46 | $-0.01 | $0.31 | $0.48 | $-0.69 | $-0.18 | $0.16 | $0.26 | $-0.75 | $-0.53 | $-0.23 | $-0.06 | $-1.17 | $-0.72 | $-0.48 | $-0.21 | $-0.98 | $-0.73 | $-0.47 | $-0.53 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.91% | 0.61% | 0.32% | 2.97% | 0.92% | 1.27% | 1.11% | 1.73% | 0.96% | 1.40% | 0.75% | 1.83% |
According to undefined Wall Street analysts, Oscar Health's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to OSCR previous annual EPS of $NaN (undefined).
Oscar Health Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| BHG | NeueHealth | $16.35 | $7.68K | 46872.48% | Hold |
| CVS | CVS Health | $56.05 | $98.50 | 75.74% | Buy |
| HUM | Humana | $271.35 | $445.86 | 64.31% | Hold |
| CNC | Centene | $58.83 | $92.20 | 56.72% | Buy |
| ELV | Elevance Health | $400.70 | $538.74 | 34.45% | Buy |
| OSCR | Oscar Health | $15.98 | $20.20 | 26.41% | Buy |
| MOH | Molina Healthcare | $292.19 | $349.38 | 19.57% | Hold |
| CI | Cigna | $322.45 | $318.74 | -1.15% | Buy |
| UNH | UnitedHealth Group | $589.65 | $577.00 | -2.15% | Buy |
| ALHC | Alignment Healthcare | $11.17 | $9.50 | -14.95% | Buy |
| CLOV | Clover Health Investments | $3.21 | $2.15 | -33.02% | Hold |